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Abstract 
In this work, Dex-HEMA-Co-PNIPAAm nanogels containing Isoniazid antibiotic were made. Characteristic features of nanogels were 
studied by Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS) and scanning electron microscopy (SEM). Drug 
loading capacity and entrapment efficiency were determined. In vitro drug release amount was estimated at room and body temperature. 
Biocompatibility of gels was investigated through cytotoxicity assay. Finally antimicrobial properties of synthesized gels were studied. It was 
shown from the experimental data that the nanogels size after drug loading increased about 1-2%. %Isoniazid loading and %entrapment 
efficiency were in the range of 15-22% and 37-48% respectively.  After 10 days of degradation ca. 80% at 25ºC and ca. 90% at 37ºC of the 
nanogel structures were destructed. No significant toxic product produced while degradation and all nanogels depicted good 
biocompatibility. No antimicrobial features observed through the test condition against gram negative E Coli.   
Keywords: nanogel, Isoniazid, Dex-HEMA-PNIPAAm, MTT, Antibacterial. 
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1 Introduction 
n recent years, with the development of 
pharmacy many efforts have been done to 
improve the drugs performance and reduce 
the drugs side effects. Due to low drug 
absorption, fast metabolism and rapid 
elimination of drug from body, drug 
concentration dose not stay steady (Haddadi-
Asl, 2011). To solve these types of problems 
introducing new kinds of drug delivery systems 
using drug carriers seems necessary.      
Drug delivery includes any formulation and 
method capable of drugs molecules convey in to 
the body. Such systems are prepared in different 
kinds, like micro/nano particles, micro/nano 
capsules, gels and hydrogels, liposomes, micelles 
and dendrimers (Patel Kundan, 2012, .Oreilly, 
2013. Hang, 2010., Mohammadpour, 2012., 
Michelle, 2013). In addition to drug 
transportation, drug delivery will enhance drug 
release, distribution and bioavailability. 
Lots of materials can be used as drug carriers 
such as metals, ceramics, biomaterials, 
composites and polymers. Among these, in 
accordance with cheapness, light weight, high 
chemical resistance and different physical, 
chemical and mechanical properties polymers 
can be suitable and worthy candidate as a 
pharmaceutics carrier. Polymers can be used in 
the forms of synthetic, natural or either a 
combination of both types (Gemma, ***. Zhe, 
2013. Franssen, 1999, Huang, 2004).  
Biodegradable polymers which mostly have 
ester, amide and ether functional group in their 
structure can break down to pieces. If they are 
utilized as drug carrier they can release drugs as 
they are degrading.  As the polymer is degrading 
it converted to the small parts that can be 
excreted from the body or can be used for 
microorganism in biological process (Aguilar, 
2013, Qiu, 2009, Dijk-Wolthuis, 1997,).  
Polysaccharides are a group of natural polymers 
that can be digested enzymatically.  In Dextran, a 
polysaccharide made of glucose molecules, the 
linear and main chain consists of α-1, 6 
glycosidic linkages between glucose molecules, 
and branches begin from α-1, 3 links. Dextran 
hydrolyze or dextranase degrade the dextran by 
endohydrolysis of α-1, 6 glycosidic linkages. 
Hydrogels, 3D hydrophilic networks, may be 
building even by physical or chemical cross 
links. High amount of water can be absorbed by 
gels and duo to this feature gels are like body 
tissue. Hence, gels show good biocompatibility 
when using as drug carriers. Stimuli sensitive 
hydrogels can control the time of drug release by 
phase changes and transient when facing stimuli. 
Stimuli can be physical like temperature, light or 
electrical and magnetic fields, chemical like pH 
and finally biological (Franssen, 1999, Dijk-
Wolthuis, 1997, Huang, 2004, Lui, 2011). 
Temperature or thermo sensitive gels are among 
the most investigated drug delivery systems, in 
which swelling/deswelling occur as the 
environment temperature changes. In this way 
drug will release in an on/off manner (Lowe, 
2005, Georgiou, 2011).  
Poly N-isopropylacrylamide (PNIPAAm) and its 
copolymers are widely used in thermo sensitive 
carrier design. This polymer shows negative 
behavior, which means that they show lower 
critical solution temperature. In the simplest way 
at low temperature the drug will be released and 
on high temperatures the system will be off 
(Perju, 2011, Kurecic, 2012, Huang,2004) . 
We have synthesized and characterized a novel 
drug delivery system previously (Jafari, 2015). 
Our system was consisting of dextran 
biodegradable natural polymer functionalized by 
adding hydroxyl ethyl Meta Acrylate (HEMA) to 
add hydrolysable group which was then 
copolymerized by PNIPAA to make 
thermosensitive nanogels. Swelling and LCST 
temperature of the gels were determined 
carefully.  In this work Isoniazid as a model drug 
was loaded to the nanogels and drug loading 
parameters were evaluated. Thereafter dug 
release, degradation, biocompatibility and 
antimicrobial features were studied. 
 
I 
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2 Experimental methods   
2.1 Materials 
 
Dextran was obtained from Fluka. N-
Isopropylacrylamide (NIPAAm) and 2-Hydroxy-
4’-(2-hydroxyethoxy)-2-methylpropiophenone 
(Irga cure 2959) and MTT color were purchased 
from Aldrich. 2-Hydroxyethyl methacrylate, 1, 1-
Carbonyldiimidazole, 4-(Dimethylamino) 
pyridine (DMPA), anhydrous Magnesium 
sulphate (MgSO4), N, N’- 
Methylenediacrylamide (MBA) and mono and 
dibasic sodium hydrogen phosphate were 
available from Merck. Isoniazid, dialysis tube 
(12000 Dalton) and L929 cell line were provided 
by Iran Pasture institute.  Triton X-100 and 
Dimethyl sulfoxide were obtained from scharlau. 
Hydroquinone monomethyl ether, lecithin and 
HCl were provided from Riddle, Pasargad novin 
and Chem.-Lab, respectively.  Tetra hydro- furan 
(THF), ethyl acetate and chloroform were 
provided by Dae-Jung, South Korea. 
 
2.2 Preparation of Isoniazid loaded nanogel 
 
Isoniazid loaded nanogels were prepared 
exactly in the same procedure as nanogels were 
synthesized previously. In a few words, freeze 
dried Dex-HEMA, obtained by coupling the 
hydroxyl group of HEMA to dextran as 
described by Dijk- Wolthuis, NIPAAm 
monomer, photo initiator, cross linking agent 
and Isoniazid with various amounts as given in 
table 1 were mixed and dissolved in PBS (pH=7). 
Afterward, these dispersions were added to the 
thin soy lecithin film, which was gained after 
vacuum evaporation of lecithin-chloroform 
solution. Resulting dispersions were mixed 
completely and were left motionless overnight.  
Finally, prepared dispersions were extruded 20 
times, through a syringe coupled to 450 nm 
filters to make nano sized polymerization 
reactors.  Subsequently to avoid polymerization 
outside the formed liposomes the dispersions 
were diluted and then after, radical 
polymerization of samples commenced by 30 
minutes UV irradiation. The end products were 
achieved after liposomes washed out using triton 
x-100. 
 
2.3 Characterization of Isoniazid loaded 
nanogel 
The structures of Isoniazid loaded nanogels, 
from 400-4000 cm-1, were investigated by means 
of Fourier transform infrared (ATR-FTIR, 
Bruker). Each spectrum was resulted from 32 
times scan and no preparation was exerted to the 
nanogels solution prior to study. 
The particles size and size changes due to 
drug loading, after suspending the nanogels in 
distilled water with viscosity of 0.89 CP, were 
evaluated by dynamic light scattering method 
(DLS, Brookhaven Instrument Corporation, 
Brookhaven, Georgia, US) at 657nm.  
The surface morphology of nanogels and 
Isoniazid loaded nanogels were monitored using 
scanning electron microscopy (SEM, Seron 
Technologies Inc., AIS 2100).  Samples were 
coated by gold before scan to make their surface 
conductive.  
 
Table 1: Composition and ingredients amount in 
feed   
Sample No. 1 2 3 4 5 
Dex-HEMA to NIPAAm 
monomer ratio 
0.5 1 2 2 0.5 
Cross linking agent (gr) 0.01 0.02 0.01 0.03 0.03 
Photo initiator (gr) 0.01 0.01 0.01 0.01 0.01 
Isoniazid (gr) 2 2 2 2 2 
 
2.4 Loading capacity and efficiency 
evaluation 
 
To study the nanogel yield (NY), Isoniazid 
loading capacity (LC) and encapsulation 
efficiency (EE), Isoniazid loaded nanogel 
suspensions were centrifuged at room 
temperature for 20 minutes at 10000 rpm. The 
precipitate that was consisting of Isoniazid 
loaded nanogels were collected for additional 
procedure such as liposome lyses and frees 
drying. The supernatants containing free 
Isoniazid were gathered and investigated by UV-
VIS spectrophotometer at the wavelength of 263 
nm to find out free Isoniazid concentration.  
The nanogel yield, Isoniazid loading percent 
and entrapment efficiency of nanogels were 
computed as follow: 
 
% 𝑁𝑌 =
𝑛𝑎𝑛𝑜𝑔𝑒𝑙𝑠 𝑤𝑒𝑖𝑔ℎ𝑡 × 100
𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 + 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡
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% 𝐿𝐶 (
𝜇𝑔
𝑚𝑙
)
=
(𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡 − 𝑓𝑟𝑒𝑒 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡) × 100
𝑛𝑎𝑛𝑜𝑔𝑒𝑙𝑠 𝑤𝑒𝑖𝑔ℎ𝑡
 
% 𝐸𝐸 (
𝜇𝑔
𝑚𝑙
)
=
(𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡 − 𝑓𝑟𝑒𝑒 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡) × 100
𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑖𝑠𝑜𝑛𝑖𝑎𝑧𝑖𝑑 𝑎𝑚𝑜𝑢𝑛𝑡
 
 
 
2.5 In vitro release studies 
 
The in vitro drug release from Dex-HEMA-
Co-PNIPAAm nanogels was tested by dialysis 
method. Particular mass of lyophilized Isoniazid 
loaded gels were weighted and subsequently 
suspended in 3 ml of PBS (pH = 7.4) and poured 
in individuals dialysis bag. Afterwards each 
dialysis bag was placed in separate glass beaker 
filled with 15 ml of PBS (pH = 7.4), incubated at 
37 ºC, while was stirred. At different time points, 
the absorptions of PBS solution, out of dialysis 
tube, were measure by UV-VIS spectroscopy 
(LKB Biochrom 4050 ultrospec II UV-VIS 
spectrophotometer) at the wavelength of 263 nm 
to find out the released Isoniazid concentration.  
 
2.6 Hydrolytic degradation studies 
 
5 mg of dispersed nanogels in PBS buffer 
solution were poured in polyethylene tubes and 
then the tubes were incubated at 37ºC for 14 
days. At different time intervals, sample were 
collected and probed by DLS to evaluate the 
nanogels diameter changes which represent the 
degradation of the nanogels. 
 
2.7 Biocompatibility studies 
 
The biocompatibility studies were performed 
by cytotoxicity and cellular viability using MTT 
(3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
Diphenyltetrazolium Bromide) assay. The 
cytotoxicity of Isoniazid loaded five different 
series of nanogels were determined facing L929 
cells. A 96- well was used in order to seeding 
cells. Each well was then filled with 100 µL of 
DMEM medium with 10 % PBS and was 
maintained at the temperature of 37 ºC in CO2 
atmosphere. One day in the rear of plating, 
50,100,200, 500 µg ml-1  of Isoniazid loaded 
nanogels were added to the wells. After 24, 48, 
72 hr the medium was removed, washed and 
then 50 µL of 5 µg ml-1  MTT solution in PBS 
was added to each well and the plate was kept in 
37 ºC for 3-4 hr. the medium was removed and 
150 µL of DMSO containing formazan salt was 
added to each well and read on microplate 
reader. Tests were performed in triplicate. The 
absorbance of samples was observed at 570 nm, 
which is sign of cell growth and proliferation.   
 
2.8 Antimicrobial studies 
 
The antimicrobial specification of isoniazid 
loaded nanogels were assest against E Coli 
(ATCC 25912, PTCC 1399), gram negatine 
organism, by help of zone of inhibition test. 1.5* 
108 CFU ml-1 of E Coli was prepares and 
cultivated on LB Agar medium. The suspention 
of 200 mg ml-1 of samples were made in distiled 
water . disks were soaked in sample suspentions 
and then were placed on plated. Plates were 
incubated at 37ºC for 72 hr.  
3 Results and discussion 
3.1 Isoniazid loaded nanogels 
characterization 
Figure 1 illustrat the isoniazid loaded 
nanogels spectra. Peaks relating to water (OH~ 
1630, H-O-H~3300) are vividly distinguishable. 
Peaks belong to Free NH2 (~1220), NH bend 
(~1650), pyridine group (~ 1440) of isoniazid 
could been recognized, too.  
The size, size increase of drug loaded 
nanogels to empty nanogels and PDI mesured 
by DLS are given in table 2 .  
SEM images have demonstrate the 
morphology and size of nanogels. The nanogel 
were almost spherical and had an smoot 
surface, and size range about 400nm which is 
given in table 2 with more detailes.  From the 
camparison of size data catched by both method 
it is notable that possibly because of freez dried 
particle cogulating to each other bigger size 
have been gotten. 
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Figure 1. Isoniazid loaded nanogels FTIR 
spectra 
 
Table 2:  Size and size distribution obtained 
by DLS and SEM comparison 
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1 339.9 1.46 0.255 424.2 2.38 
2 349.8 0.75 0.263 565 2.52 
3 354 1.51 0.269 406.6 0.95 
4 329 0.86 0.238 352.5 1.48 
5 373.5 1.55 0.268 439.3 1.99 
 
For instance figure 2 represents DLS and 
SEM images of sample 2 with and without 
Isoniazid.   
 
  
  
Figure 2. (top row) Isoniazid free nanogel size, 
(bottom row) Isoniazid loaded nanogels size 
measure by DLS and SEM respectively 
 
3. 2 Loading capacity, encapsulation 
efficiency and nanogels yield 
 
The amounts of Isoniazid which loaded in 
nanogels were measured by subtracting the free 
Isoniazid value from initial Isoniazid content. 
Nanogels yield, Isoniazid loading and 
entrapment efficiency were calculating according 
to formulas (1) to (3) are reported in table 3. 
As it is obvious, the less the cross linking 
agent was used the more drug loading and 
entrapment efficiency percent were resulted. 
 
Table 3: Characteristic of Isoniazid loaded 
nanogels 
Sample  
name 
% 
nanogels 
yield 
% Isoniazid 
loading 
% entrapment 
efficiency 
1 73.42 21.77 48.11 
2 72.96 18.32 40.31 
3 72.92 20.86 45.78 
4 72.51 20.90 37.81 
5 71.85 15.29 38.18 
 
3. 3 In vitro Isoniazid release study 
 
while a part of synthesized nanogels 
consisted of PNIPAAm, a thermosensitive 
polymer, whole nanosized carrier found the 
thermoresponding behavior in which the gel 
swell and deswell according to temperature 
shifts and the net mesh size could change 
automatically. Hence the release behavior in 
both temperatures limits, below and upper the 
LCST temperature, were studied to evaluate the 
differences in release mechanism. The results of 
Isoniazid release during 10 days from gels at 
25ºC and 37ºC is depicted in figure 3. 
400 1200 2000 2800 3600
1
2
3
4
5
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As the results show at 37º C and at the 
temperature upper LCST which is ca. 32.5º C,  in 
the physiological conditions nanogels shrink and 
the portion of their trapped content were 
released suddenly which is observable as a burst 
release in figure 3. After about 1 hr that all 5 
series of freeze dried Isoniazid loaded nanogels 
reached the media temperature they deswelled 
and 69.88, 80.72, 88.52, 79.38 and 67.82 % of their 
content including Isoniazid released 
respectively. Then the release regime in all gels 
followed the same way slowly by the 
degradation mechanism and finally after 10 days 
the drug release percent touched the 82.61, 90.38, 
96.80, 89.73 and 79.95% respectively. The sample 
2 having the mix combination of the highest ratio 
of Dex-HEMA to PNIPAAm, having the most 
amount of hydrolysable ester bond in its 
structure and cross linking agent of 0.01 gr whish 
was the less value showed the most amount of 
release among other samples. Next ranks of 
Isoniazid release belong to samples 3 and 4 
respectively.  The effect of Dex-HEMA to 
PNIPAAm ratio that results in better 
degradation were more serious than the cross 
linking agent. Last places were occupied by 
sample 1 and 5 by the previous analysis.  
At 25ºC that is bellow LCST temperature the 
release behavior was different. At this 
temperature nanogels swelled and the release 
mechanism was controlled by diffusion. The 
ultimate values for Isoniazid release after 10 
days were 80.46, 80.08, 79, 77.83 and 77.97 for all 
the 5 series. As the results represent the values 
are almost similar and no tangible differences 
were filled, but even in this case the impact of 
cross linking agent can be seen. The more the 
cross linking agent observed the less swelling 
and consequently less release attached. 
 
 
 
Figure. 3. Drug release% from nanogels at 25 
and 37ºC 
3. 4 Isoniazid loaded nanogels degradation 
 
To study the hydrolytic degradation, 
Isoniazid loaded nanogels of different 
composition incubated in physiological 
condition. At very beginning times an increase in 
gels size could be observed which sign of freeze 
dried gel swelling was. The swelling was not 
considerable because the testes were holding on 
upper LCST temperature in which nanogels 
were in their shrinking form. Then after the gels 
sizes have been decreased slowly within 2 
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weeks. Figure 4 shows the percent of particle size 
decrees as a function of degradation time.  
As results depict, size decrease due to 
hydrolytic degradation occurred most in sample 
4, 3, 2, 1 and 5 respectively that can be related to 
the quantity of hydrolysable group which is 
found in Dex- HEMA part of the nanogels.  
 
Figure 4. Particle size decrease % due to 
hydrolytic degradation 
 
3. 5 In vitro cytotoxicity assay 
 
 The cytotoxicity of Isoniazid loaded nanogels 
against L929 cells was evaluated and outcomes 
are represented in figure 5.   
 
Figure. 5. Cell viability (proliferation) during24, 
48,72hr at concentration: 50,100,200,500µg/ml 
At the same concentration of Isoniazid loaded 
nanogels, the more the time was the higher cell 
survival observed. On the other hand, at similar 
time intervals, as the concentration raised, the 
cell viability fallen. 
 
3. 6 In vitro antimicrobial assay 
 
The antimicrobial behavior of nanogels tested 
against gram negative E Coli. Unfortunately, not 
any traces of inhibition zone were detected in all 
5 series of samples. According to Gerald Tritz 
work inhibitory nature of E coli by Isoniazid 
depends on the initial cell concentration, 
Isoniazid concentration, and chemical 
composition of the medium, hence theses 
parameters could be the origin of losing 
antimicrobial feature of the Isoniazid loaded 
nanogels. 
4. Conclusion 
In this work, Isoniazid loaded biodegradable 
and thermosensitive nanogels were prepared 
through UV polymerization method. By 
incorporating PNIPAAm in the nanogels 
structure the thermosesitivity characteristic was 
given to the gels which affected the degradation 
and drug release from the gels in physiological 
condition. Hydrolytically degradable 
specification also donated to nanogels because of 
Dex-HEMA portion. The degradation product 
were nontoxic but had not any antimicrobial 
features. Totally these nanogels seem to be a 
good candidate in controlled drug delivery.    
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